LJPC

La Jolla Pharmaceutical Company
6.23
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
6.23
Volume 0
Bid Price 6.54
Ask Price 6.25
News -
Company Name Stock Ticker Symbol Market Type
La Jolla Pharmaceutical Company LJPC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 6.23 19:00:00
Open Price Low Price High Price Close Price Prev Close
6.23 6.23
Trades Volume Avg Volume
0 0 -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 6.23 USD

Period:

Draw Mode:

La Jolla Pharmaceutical Company Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 155.36M 24.94M 14.86M $ 75.72M $ 7.01M 0.57 51.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 2.07k 7.00%

more financials information »

La Jolla Pharmaceutical News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical LJPC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

La Jolla Pharmaceutical Description

La Jolla Pharmaceutical Co is a biopharmaceutical company. The company's main activity is the discovery, development, and commercialization of innovative therapies that improve patients' life-threatening conditions. The company's portfolio consists of an angiotensin II formulation, which regulates blood pressure; a formulation of hepcidin, an endogenous peptide hormone that regulates iron metabolism; and an antibiotic approved by the U.S. Food and Drug Administration.